Sort
30,917 grants matching “tumor microenvironment”
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
$630,691Renier Joseph Brentjens · Roswell Park Cancer Institute Corp · U01 · FY2023 · CA
Collagen Signaling in Pancreatic Cancer
$630,684Howard C Crawford · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2024 · CA
MS4A7 in tumor resistance to immunotherapy
$630,650Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Strategies to Reduce Global Health Disparities in Cervical Cancer
$630,506T.-C. Wu · Johns Hopkins University · R01 · FY2025 · CA
Magnetic Resonance Fingerprinting of Tumor Vascular Perfusion and Acidosis
$630,474Christopher A Flask · Case Western Reserve University · R01 · FY2024 · CA
Metformin for chemoprevention of lung cancer in obese subjects at high risk
$630,457Saikrishna Yendamuri · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$630,437Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
$630,404Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Creation of in vivo active chemical probes for CAMKK2 to treat cancer
$630,383David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Data Generation
$630,314James Korkola · Oregon Health & Science University · U54 · FY2017 · HG
ER stress-driven IRE1a-XBP1 signaling in lung cancer
$630,307Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Data Generation
$630,269James Korkola · Oregon Health & Science University · U54 · FY2016 · HG
Shark Radiotherapy for the Treatment of Triple-Negative Breast Cancer
$630,171Aaron Matthew Lebeau · University Of Wisconsin-Madison · R01 · FY2025 · CA
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
$630,142Heike Elizabeth Daldrup-Link · Stanford University · U24 · FY2022 · CA
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
$630,136Yoshihiro Izumiya · University Of California At Davis · R01 · FY2018 · CA
Project 1:The Carolina Breast Cancer Study
$630,076Melissa A. Troester · Univ Of North Carolina Chapel Hill · P50 · FY2018 · CA
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment
$630,053Shridar Ganesan · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Targeting STAT3 to enhance anti-tumor immunity
$630,039Daniel E Johnson · University Of California, San Francisco · R01 · FY2022 · DE
Advancing RAS pathway targeted therapy in NF1-MPNST: effects of SHP2 and CDK4/6 inhibitors on the tumor and the tumor immune microenvironment
$630,037Christine Anne Pratilas · Johns Hopkins University · R01 · FY2025 · CA
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE
$630,034Kooresh Isaac Shoghi · Washington University · U24 · FY2018 · CA
Cancer Center Support Grant
$630,000Gerold Bepler · Wayne State University · P30 · FY2020 · CA
Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors
$629,966Albert Folch · University Of Washington · R01 · FY2024 · CA
Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma
$629,947Damian J. Green · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Molecular Genomics Core
$629,824John David Carpten · University Of Southern California · P30 · FY2022 · CA
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
$629,761Rebecca L Aft · Washington University · R01 · FY2021 · CA